Alternative splicing of CD45 pre-mRNA is uniquely obedient to conditions in lymphoid cells

Biochimica et Biophysica Acta - Gene Structure and Expression

Volumn 1446, Issue 3, 1999, Pages 317-333

  Ten Dam, Gerdy B ^a   Wieringa, Bé ^a   Poels, Lambert G ^a  

^a RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

Author keywords

Alternative splicing; CD45; SR proteins

Indexed keywords

CD45 ANTIGEN; MESSENGER RNA;

ALTERNATIVE RNA SPLICING; ARTICLE; CONTROLLED STUDY; EXON; GENETIC TRANSFECTION; HEMATOPOIESIS; IMMUNOBLOTTING; INTRON; LYMPHOID TISSUE; MOUSE; NONHUMAN; PH; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING;

ALTERNATIVE SPLICING; ANIMALS; ANTIGENS, CD45; BLOTTING, WESTERN; CELL MEMBRANE; CLONING, MOLECULAR; COS CELLS; CYTOPLASM; GENE EXPRESSION; HELA CELLS; HUMANS; LYMPHOCYTES; MICE; MICE, TRANSGENIC; NUCLEAR PROTEINS; PHOSPHOPROTEINS; PLASMIDS; PROTEIN ISOFORMS; RNA PRECURSORS; RNA-BINDING PROTEINS; TRANSFECTION;

MUS MUSCULUS;

EID: 0032773131     PISSN: 01674781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-4781(99)00119-0     Document Type: Article

References (45)

1. Thomas M.L. The leukocyte common antigen family. Annu. Rev. Immunol. 7:1989;339-369.
2. Trowbridge I.S., Thomas M.L. CD45: an emerging role as a protein tyrosine phosphatase required for lymphocyte activation and development. Annu. Rev. Immunol. 12:1994;85-116.
3. Streuli M., Saito H. Regulation of tissue-specific alternative splicing: exon-specific cis-elements govern the splicing of leukocyte common antigen pre-mRNA. EMBO J. 8:1989;787-796.
4. Tsai A.Y., Streuli M., Saito H. Integrity of the exon 6 sequence is essential for tissue-specific alternative splicing of human leukocyte common antigen pre-mRNA. Mol. Cell. Biol. 9:1989;4550-4555.
5. Rothstein D.M., Saito H., Streuli M., Schlossman S.F., Morimoto C. The alternative splicing of the CD45 tyrosine phosphatase is controlled by negative regulatory trans-acting splicing factors. J. Biol. Chem. 267:1992;7139-7147.
6. Lefrancois L., Goodman T. Developmental sequence of T200 antigen modifications in murine T cells. J. Immunol. 139:1987;3718-3724.
7. Akbar A.N., Terry L., Timms A., Beverley P.C., Janossy G. Loss of CD45R and gain of UCHL1 reactivity is a feature of primed T cells. J. Immunol. 140:1988;2171-2178.
8. Birkeland M.L., Johnson P., Trowbridge I.S., Pure E. Changes in CD45 isoform expression accompany antigen-induced murine T-cell activation. Proc. Natl. Acad. Sci. USA. 86:1989;6734-6738.
9. Bell E.B. Function of CD4 T cell subsets in vivo: expression of CD45R isoforms. Semin. Immunol. 4:1992;43-50.
10. Screaton G.R., Caceres J.F., Mayeda A., Bell M.V., Plebanski M., Jackson D.G., Bell J.I., Krainer A.R. Identification and characterization of three members of the human SR family of pre-mRNA splicing factors. EMBO J. 14:1995;4336-4349.
11. Zahler A.M., Lane W.S., Stolk J.A., Roth M.B. SR proteins: a conserved family of pre-mRNA splicing factors. Genes Dev. 6:1992;837-847.
12. Fu X.D. The superfamily of arginine/serine-rich splicing factors. RNA. 1:1995;663-680.
13. Chabot B. Directing alternative splicing: cast and scenarios. Trends Genet. 12:1996;472-478.
14. Zahler A.M., Neugebauer K.M., Lane W.S., Roth M.B. Distinct functions of SR proteins in alternative pre-mRNA splicing. Science. 260:1993;219-222.
15. Caceres J.F., Stamm S., Helfman D.M., Krainer A.R. Regulation of alternative splicing in vivo by overexpression of antagonistic splicing factors. Science. 265:1994;1706-1709.
16. ten Dam G.B., Poels L.G., Wieringa B. Cell surface GPI-anchoring of CD45 isoforms. Mol. Biol. Rep. 25:1998;197-204.
17. Hall L.R., Streuli M., Schlossman S.F., Saito H. Complete exon-intron organization of the human leukocyte common antigen (CD45) gene. J. Immunol. 141:1988;2781-2787.
18. Streuli M., Hall L.R., Saga Y., Schlossman S.F., Saito H. Differential usage of three exons generates at least five different mRNAs encoding human leukocyte common antigens. J. Exp. Med. 166:1987;1548-1566.
19. van Deursen J., Lovell Badge R., Oerlemans F., Schepens J., Wieringa B. Modulation of gene activity by consecutive gene targeting of one creatine kinase M allele in mouse embryonic stem cells. Nucleic Acids Res. 19:1991;2637-2643.
20. van Deursen J., Wieringa B. Targeting of the creatine kinase M gene in embryonic stem cells using isogenic and nonisogenic vectors. Nucleic Acids Res. 20:1992;3815-3820.
21. Steeghs K., Oerlemans F., Wieringa B. Mice deficient in ubiquitous mitochondrial creatine kinase are viable and fertile. Biochim. Biophys. Acta. 1230:1995;130-138.
22. Zapata J.M., Pulido R., Acevedo A., Sanchez Madrid F., de Landazuri M.O. Human CD45RC specificity. A novel marker for T cells at different maturation and activation stages. J. Immunol. 152:1994;3852-3861.
23. Smith S.H., Brown M.H., Rowe D., Callard R.E., Beverley P.C. Functional subsets of human helper-inducer cells defined by a new monoclonal antibody, UCHL1. Immunology. 58:1986;63-70.
24. Ramaekers F., van Niekerk C., Poels L., Schaafsma E., Huijsmans A., Robben H., Schaart G., Vooijs P. Use of monoclonal antibodies to keratin 7 in the differential diagnosis of adenocarcinomas. Am. J. Pathol. 136:1990;641-655.
25. Kreis T.E. Microinjected antibodies against the cytoplasmic domain of vesicular stomatitis virus glycoprotein block its transport to the cell surface. EMBO J. 5:1986;931-941.
26. Roth M.B., Murphy C., Gall J.G. A monoclonal antibody that recognizes a phosphorylated epitope stains lampbrush chromosome loops and small granules in the amphibian germinal vesicle. J. Cell Biol. 111:1990;2217-2223.
27. Okumura M., Matthews R.J., Robb B., Litman G.W., Bork P., Thomas M.L. Comparison of CD45 extracellular domain sequences from divergent vertebrate species suggests the conservation of three fibronectin type III domains. J. Immunol. 157:1996;1569-1575.
28. Saga Y., Lee J.S., Saraiya C., Boyse E.A. Regulation of alternative splicing in the generation of isoforms of the mouse Ly-5 (CD45) glycoprotein. Proc. Natl. Acad. Sci. USA. 87:1990;3728-3732.
29. Fujii Y., Okumura M., Inada K., Nakahara K., Matsuda H. CD45 isoform expression during T cell development in the thymus. Eur. J. Immunol. 22:1992;1843-1850.
30. Wallace V.A., Fung Leung W.P., Timms E., Gray D., Kishihara K., Loh D.Y., Penninger J., Mak T.W. CD45RA and CD45RBhigh expression induced by thymic selection events. J. Exp. Med. 176:1992;1657-1663.
31. Ratech H., Denning S., Kaufman R.E. An analysis of alternatively spliced CD45 mRNA transcripts during T cell maturation in humans. Cell. Immunol. 177:1997;109-118.
32. Rogers P.R., Pilapil S., Hayakawa K., Romain P.L., Parker D.C. CD45 alternative exon expression in murine and human CD4+ T cell subsets. J. Immunol. 148:1992;4054-4065.
33. Hathcock K.S., Hirano H., Murakami S., Hodes R.J. CD45 expression by B cells. Expression of different CD45 isoforms by subpopulations of activated B cells CD45 expression by B cells. J. Immunol. 149:1992;2286-2294.
34. Kozieradzki I., Kundig T., Kishihara K., Ong C.J., Chiu D., Wallace V.A., Kawai K., Timms E., Ionescu J., Ohashi P., Marth J.D., Mak T.W., Penninger J.M. T cell development in mice expressing splice variants of the protein tyrosine phosphatase CD45. J. Immunol. 158:1997;3130-3139.
35. Gallego M.E., Gattoni R., Stevenin J., Marie J., Expert Bezancon A. The SR splicing factors ASF/SF2 and SC35 have antagonistic effects on intronic enhancer-dependent splicing of the beta-tropomyosin alternative exon 6A. EMBO J. 16:1997;1772-1784.
36. Krainer A.R., Conway G.C., Kozak D. The essential pre-mRNA splicing factor SF2 influences 5′ splice site selection by activating proximal sites. Cell. 62:1990;35-42.
37. Ge H., Manley J.L. A protein factor, ASF, controls cell-specific alternative splicing of SV40 early pre-mRNA in vitro. Cell. 62:1990;25-34.
38. Fu X.D., Maniatis T. Factor required for mammalian spliceosome assembly is localized to discrete regions in the nucleus. Nature. 343:1990;437-441.
39. Cavaloc Y., Popielarz M., Fuchs J.P., Gattoni R., Stevenin J. Characterization and cloning of the human splicing factor 9G8: a novel 35 kDa factor of the serine/arginine protein family. EMBO J. 13:1994;2639-2649.
40. Xiao S.H., Manley J.L. Phosphorylation-dephosphorylation differentially affects activities of splicing factor ASF/SF2. EMBO J. 17:1998;6359-6367.
41. Misteli T., Caceres J.F., Clement J.Q., Krainer A.R., Wilkinson M.F., Spector D.L. Serine phosphorylation of SR proteins is required for their recruitment to sites of transcription in vivo. J. Cell Biol. 143:1998;297-307.
42. Popielarz M., Cavaloc Y., Mattei M.G., Gattoni R., Stevenin J. The gene encoding human splicing factor 9G8. Structure, chromosomal localization, and expression of alternatively processed transcripts. J. Biol. Chem. 270:1995;17830-17835.
43. Jumaa H., Nielsen P.J. The splicing factor SRp20 modifies splicing of its own mRNA and ASF/SF2 antagonizes this regulation. EMBO J. 16:1997;5077-5085.
44. Deans J.P., Boyd A.W., Pilarski L.M. Transitions from high to low molecular weight isoforms of CD45 (T200) involve rapid activation of alternate mRNA splicing and slow turnover of surface CD45R. J. Immunol. 143:1989;1233-1238.
45. Craig W., Poppema S., Little M.T., Dragowska W., Lansdorp P.M. CD45 isoform expression on human haemopoietic cells at different stages of development. Br. J. Haematol. 88:1994;24-30.